Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients

Journal of Medical Virology

Volumn 70, Issue 4, 2003, Pages 581-587

  Abbate, Isabella ^a   Romano, Mario ^a   Longo, Roberta ^a   Cappiello, Giuseppina ^a   Lo Iacono, Oreste ^b,c   Di Marco, Vito ^c   Paparella, Concetta ^a   Spanǒ, Alberto ^a   Capobianchi, Maria Rosaria ^b  

^a SANDRO PERTINI HOSPITAL   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

HCV; IFN; ISG; Liver injury; mRNA

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; ALPHA INTERFERON RECEPTOR 1; GAMMA INTERFERON; GENE PRODUCT; INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; STAT1 PROTEIN; STAT1ALPHA PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; FATTY LIVER; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LIVER BIOPSY; LIVER INJURY; MALE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SIGNAL TRANSDUCTION; VIRUS LOAD;

ADULT; AGED; BIOPSY; DNA-BINDING PROTEINS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERONS; INTERLEUKIN-18; LIVER; LIVER DISEASES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHOSPHOPROTEINS; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 0038046073     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10433     Document Type: Article

References (36)

1. Abbate I, Dianzani F, Capobianchi MR. 2000. Activation of signal transduction and apoptosis in healthy lymphomonocytes exposed to bystander HIV-1-infected cells. Clin Exp Immunol 122:1-9.
2. Bantel H, Lugering A, Poremba C, Lugering N, Held J, Domschke W, Schulze-Osthoff K. 2001. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology 34:758-767.
3. Baroni GS, Pastorelli A, Manzin A, Benedetti A, Marucci L, Solforosi L, Di Sario A, Brunelli E, Orlandi F, Clementi M, Macarri G. 1999. Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Thl-like response in chronic hepatitis C. Liver 19:212-219.
4. Bigger CB, Brasky KM, Landford RE. 2001. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 75:7059-7066.
5. Calabrese F, Pontisso P, Pettenazzo E, Benvegnu L, Vario A, Chemello L, Alberti A, Valente M. 2000. Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology 31:1153-1159.
6. Castelruiz Y, Larrea E, Boya P, Civeira MP, Prieto J. 1999. Interferon alfa subtypes and levels of type I interferons in the liver and peripheral mononuclear cells in patients with chronic hepatitis C and controls. Hepatology 29:1900-1904.
7. Csiszar A, Nagy GY, Gergely P, Pozsonyi T, Pocsik E. 2000. Increased interferon-γ (IFN-γ), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 122:464-470.
8. Dianzani F, Capobianchi MR. 1997. Interferon as a possible pathogenetic factor in HIV infection. Biotechnologia Aplicada 14:81-90.
9. Fantuzzi G, Reed D, Qi M, Scully S, Dinarello CA, Senaldi G. 2001. Role of interferon regulatory factor-1 in the regulation of IL-18 production and activity. Eur J Immunol 31:369-375.
10. Gale M, Blakely CM, Kwieciszewski B, Tan S, Tang NM, Korth MJ, Polyak SJ, Gretch DR, Katze MG. 1998. Control of PKR protein kinase by hepatitis C virus non structural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 18:5208-5218.
11. Ghislain JJ, Wong T, Nguyen M, Fish EN. 2001. The interferoninducible Stat2:Stat1 heterodimer preferentially binds in vitro to a consensus element found in the promoters of a subset of interferonstimulated genes. J Interferon Cytokine Res 21:379-388.
12. Gil J, Esteban M. 2000. Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis 5:107-114.
13. Guo JT, Bichko VV, Seeger C. 2001. Effect of α interferon on the hepatitis C virus replicon. J Virol 75:8516-8523.
14. Heim MH, Moradpour D, Blum HE. 1999. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J Virol 73:8469-8475.
15. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. 1981. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435.
16. Larrea E, Alberdi A, Castelruiz Y, Boya P, Civeira MP, Prieto J. 2001. Expression of interferon-α subtypes in peripheral mononuclear cells from patients with chronic hepatitis C: a role for interferon-α5. J Viral Hepat 8:103-110.
17. Masaki N, Fukushima S, Hayashi S. 2002. Lower th-1/th-2 ratio before interferon therapy may favor long-term virological responses in patients with chronic hepatitis C. Dig Dis Sci 47:2163-2169.
18. Mathai J, Shimoda K, Banner BF, Mori M, Bonkovsky HL, Barnard GF. 1999. IFN-α receptor mRNA expression in a United States sample with predominantly genotype la/I chronic hepatitis C liver biopsies correlates with response to IFN therapy. J Interferon Cytokine Res 19:1011-1018.
19. McGuinness PH, Painter D, Davies S, McCaughan GW. 2000. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut 46:260-269.
20. Mizukoshi E, Kaneko S, Kaji K, Terasaki S, Matsushita E, Muraguchi M, Ohmoto Y, Kobayashi K. 1999a. Serum levels of soluble interferon α/β receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C. Hepatology 30:1325-1331.
21. Mizukoshi E, Kaneko S, Yanagi M, Ohno H, Matsushita E, Kobayashi K. 1999b. Upregulation of type-1 interferon receptor by IFN-γ. J Interferon Cytokine Res 19:1019-1023.
22. Morita K, Tanaka K, Saito S, Kitamura T, Kiba T, Fujii T, Numata K, Sekihara H. 1999. Expression of interferon receptor genes in the liver as a predictor of interferon response in patients with chronic hepatitis C. J Med Virol 58:359-365.
23. Pawlotsky J. 2000. Hepatitis C virus resistance to antiviral therapy. Hepatology 32:889-896.
24. Podevin P, Guechot J, Serfaty L, Monrand-Joubert L, Veyrunes C, Bonnefis MT, Poupon R. 1997. Evidence for a deficiency of interferon response in mononuclear cells from hepatitis C viremic patients. J Hepatol 27:265-271.
25. Poynard T, McHutchinson J, Manns M, Trepo C, Lindsay K, Goodmann Z, Ling MH, Albrecht J. 2002. Impact of pegylated interferon α-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 122:1303-1313.
26. Rodriguez-Inigo E, Bartolome J, De Lucas S, Manzarbeitia F, Pardo M, Arocena C, Gosalvez J, Oliva H, Carreno V. 1999. Histological damage in chronic hepatitis C is not related to the extent of infection in the liver. Am J Pathol 154:1877-1881.
27. Santini SM, Lapenta C, Logozzi M, Parlato S, Di Pucchio T, Belardelli F. 2000. Type I Interferon as a powerful adjuvant for monocytederived dendritic cell development and activity in vitro and in HuPBL-SCID mice. J Exp Med 191:1777-1788.
28. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu Y. 1999. The nature of the principal type-1 interferon-producing cells in human blood. Science 284:1835-1837.
29. Sobue S, Nomura T, Ishikawa T, Ito S, Saso K, Ohara H, Joh T, Itoh M, Kakumu S. 2001. Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection. J Gastroenterol 36:544-551.
30. Takeout R, Tsutsumi H, Osaki M, Haseyama K, Mizue N, Chiba S. 1998. Respiratory syncytial virus infection of human alveolar epithelial cells enhances interferon regulatory factor 1 and interleukin-1β-converting enzyme gene expression but does not cause apoptosis. J Virol 72:4498-4502.
31. Taylor DR, Shi ST, Romano PR, Barber GN, Lai MMC. 1999. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285:107-110.
32. Tsutsui H, Matsui K, Okamura H, Nakanishi K. 2000. Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol Rev 174:192-209.
33. Watanabe H, Enomoto N, Nagayama K, Izumi N, Marumo F, Sato C, Watanabe M. 2001. Number and position of mutations in the interferon (IFN) sensitivity-determining region of the gene for nonstructural protein 5A correlate with IFN efficacy in hepatitis C virus genotype 1b infection. J Infect Dis 183:1195-1203.
34. Yatsuhashi H, Fujino T, Matsumoto T, Inoue O, Koga M, Yano M. 1999. Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C. J Hepatol 30:995-1003.
35. Yokosawa N, Kubota T, Fuji N. 1998. Poor induction of interferoninduced 2′,5′-oligoadenylate synthetase (2-5 AS) in cells persistently infected with mumps virus is caused by decrease of STAT1α. Arch Virol 143:1985-1992.
36. Yu SH, Nagayama K, Enomoto N, Izumi N, Marumo F, Sato C. 2000. Intrahepatic mRNA expression of interferon-inducible antiviral genes in liver diseases: dsRNA-dependent protein kinase overexpression and Rnase L inhibitor suppression in chronic hepatitis C. Hepatology 32:1089-1095.